paperKB
coga / coga-kb
Processing
Help
Sign in
L

Lerman, Caryn

Center for Interdisciplinary Research on Nicotine Addiction, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA

TitleYearPMID
Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function. 2014 24622915
Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. 2013 23941313
Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. 2013 23249876
Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. 2012 22290489
Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials. 2012 22048466
Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. 2011 21576462
Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. 2009 19528658
Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. 2009 19169923
Supplementing high-density SNP microarrays for additional coverage of disease-related genes: addiction as a paradigm. 2009 19381300
Molecular genetics of successful smoking cessation: convergent genome-wide association study results. 2008 18519826
Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. 2008 18593715
Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. 2007 16876132
Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. 2005 15900212
Elucidating the role of genetic factors in smoking behavior and nicotine dependence. 2003 12627466
Showing 1–14 of 14